AzTrials
AzTrials

BurnsNCT01922960

Microcirculatory Assessment in Patients With Trauma and Severe Burns

A study testing micro-imaging in people with Burns and Trauma, run by University of South Alabama at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Predict the development of multiple organ failure in patients with trauma and severe burns. Read more about this study

Who is it for?
Ages 19 to 80 years
Conditions the study is for
Burns, Trauma
What is being tested?
micro-imaging
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
7 Apr 2012to Feb 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with severe burns/trauma ages 19-80. Patients undergoing elective abdominal or cardiothoracic surgery ages 19-69 years old

Who cannot join

  • Patients undergoing elective surgery < 19 years old.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of South Alabama Medical Center

    Mobile, Alabama, 36617

Other trials in United States

About this study

Predict the development of multiple organ failure in patients with trauma and severe burns.

Read the detailed description

Microvascular alterations are frequently seen in patients with sepsis, trauma, burns and those who are hemodynamically uncompensated(Shock).

The use of the Microscan is a non-invasive approach to visualize and assess impaired mucosal microcirculation in order to identify early on patients who are predisposed for MOF (multiple organ failure)

Conditions
Burns, Trauma
Being tested
micro-imaging
Keywords
trauma, multiple organ dysfunction syndrome
Medical subject headings
Burns, Wounds and Injuries, Multiple Organ Failure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • micro-imagingOther

    micro-imaging

Study groups in NCT01922960
Study groupRoleWhat they receive
micro-imagingOtherSublingual or subconjunctival micro-imaging of the microcirculation taken for 3 minute intervals at certain timepoints. Timepoints for burn/trauma subjects: Day0, Day1,Day2,Day6 \& Day7 Timepoints for general surgery population: post-induction, prior to resection, after resection,\& closing of surgical wound.
Receives: Other: micro-imaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. dysfunctional capillary density correlates with development of multiple organ failure

    Measured: approximately 1 year to assess outcome measure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2013 (estimated)
  2. Study start7 Apr 2012 (estimated)
  3. Primary completionFeb 2014
  4. Study completionFeb 2014

Why it stopped: investigators decided not to move forward with project

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01922960
Sponsor's protocol ID
12-092
Status last verified
Nov 2017
First submitted
27 Jun 2013
Last updated
29 Nov 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing micro-imaging in people with Burns and Trauma, run by University of South Alabama at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 29 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

dysfunctional capillary density correlates with development of multiple organ failure (time frame: approximately 1 year to assess outcome measure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in